SCHEMBL3585730

SCHEMBL3585730

O=C(Nc1ccc2ccccc2n1)N1CCNCC1

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
POLB P06746 1/20 0.55
NPY5R Q15761 1/20 0.52
NPC1 O15118 9/20 0.51
RAB9A P51151 7/20 0.51
KMT2A Q03164 2/20 0.50
FAAH O00519 3/20 0.49
KDM4E B2RXH2 2/20 0.49
CYP3A4 P08684 2/20 0.49
HSD17B10 Q99714 2/20 0.49
MAPK1 P28482 2/20 0.49
HTR3E A5X5Y0 1/20 0.49
USP2 O75604 1/20 0.49
HTR3B O95264 1/20 0.49
ALDH1A1 P00352 1/20 0.49
CYP1A2 P05177 1/20 0.49
ADRB1 P08588 1/20 0.49
HTR1A P08908 1/20 0.49
HTR2C P28335 1/20 0.49
SLC6A4 P31645 1/20 0.49
HTR7 P34969 1/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8489126 0.86 NPC1 (0.59) POLBNPY5RNPC1RAB9AKMT2A
SCHEMBL5139469 0.75 TSHR (0.66) RAB9AKMT2AKDM4ECYP3A4HSD17B10
SCHEMBL3954599 0.75 POLB (0.59) POLBNPC1RAB9AKMT2AFAAH
SCHEMBL11565 0.75 CYP1A2 (0.50) POLBFAAHKDM4ECYP3A4HSD17B10
SCHEMBL5956401 0.74 POLB (0.66) POLBNPC1RAB9AKMT2AFAAH
Hydrochloric Acid SCHEMBL6586965 0.74 TSHR (0.64) RAB9AKMT2AKDM4ECYP3A4HSD17B10
SCHEMBL3639088 0.74 FAAH (0.60) NPY5RNPC1RAB9AKMT2AFAAH
SCHEMBL27657075 0.73 KMT2A (0.83) NPC1RAB9AKMT2AMAPK1ADORA3
Hydrochloric Acid SCHEMBL5492077 0.73 POLB (0.68) POLBNPC1RAB9AKMT2AFAAH
SCHEMBL656655 0.72 POLB (0.97) POLBNPC1RAB9AFAAHKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100075953-A1 SUBSTITUTED PIPERAZINES, (1,4) DIAZEPINES, AND 2,5-DIAZABICYCLO (2.2.1) HEPTANES AS HISTAMINE H1 AND/OR H3 ANTAGONISTS OR HISTAMINE H3 REVERSE ANTAGONISTS GLAXO GROUP LIMITED (GB) 2010-03-25 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100075953-A1 SUBSTITUTED PIPERAZINES, (1,4) DIAZEPINES, AND 2,5-DIAZABICYCLO (2.2.1) HEPTANES AS HISTAMINE H1 AND/OR H3 ANTAGONISTS OR HISTAMINE H3 REVERSE ANTAGONISTS HRH3, HRH4, HRH2 POLB 3375/4885NPY5R 145/4885NPC1 1374/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.